← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 18, 2003Last known activity
Mar 1, 2025
Timeline
1990s
- Jun 1, 1993
FibroGen— Founded
Drugs by trial phase (14 distinct, 59 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Indications
Studied for
- Anemia
- Communicable Diseases
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Fibrosis
- Glomerulosclerosis, Focal Segmental
- Hepatic Insufficiency
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Idiopathic Pulmonary Fibrosis
- Infections
- Kidney Diseases
- Kidney Failure, Chronic
- Liver Cirrhosis
- Liver Failure
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Myelodysplastic Syndromes
- Pancreatic Neoplasms
- Pulmonary Fibrosis
- Renal Insufficiency
- Renal Insufficiency, Chronic
Recent trials (50)
- NCT06842498Lead sponsorPhase 2Mar 1, 2025
- NCT05301517Lead sponsorPhase 3Mar 16, 2022
- NCT04632940Lead sponsorPhase 3Dec 31, 2020
- NCT04621331Lead sponsorPhase 3Nov 30, 2020
- NCT04419558Lead sponsorPhase 3Aug 31, 2020
- NCT04484857Study chairPhase 3Jul 17, 2020
- NCT04484857Lead sponsorPhase 3Jul 17, 2020
- NCT04432298Lead sponsorPhase 2Jun 30, 2020
- NCT04410198Lead sponsorPhase 3Jun 1, 2020
- NCT04410198Study chairPhase 3Jun 1, 2020
- NCT04371666Lead sponsorPhase 3May 30, 2020
- NCT04076943Lead sponsorPhase 2Aug 6, 2019
- NCT03955146Lead sponsorPhase 3Jun 30, 2019
- NCT03960489CollaboratorPhase 1Jun 30, 2019
- NCT04059913Lead sponsorPhase 4Jun 11, 2019
Details
- Founded
- San Francisco, CA, US Jun 1, 1993
- Last known activity
- Mar 1, 2025